''Evaluation of the efficacy of 'TRANS-DERMAL NITRATE' in reducing the severity of 'death-rattle' (i.e 'terminal lung secretions' ) in patients dying from end stage malignancy'' - n/a
- Conditions
- 'Death-rattle' (i.e 'terminal lung secretions') in adult patients dying from end-stage malignancy
- Registration Number
- EUCTR2007-004369-16-GB
- Lead Sponsor
- St Raphael's Hospice, Surrey
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with advanced malignancy who enter the 'terminal phase' i.e (eligible for 'Integrated care pathway' for the dying)
2.Patients over 18 years of age
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1.Patients with Primary Brain Tumour
2.Patients with Cerebral Metastases
3.Patients with 'Motor Neurone Disease'
4.Patients with 'end-stage cardiac failure'
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method